TipRanks
Go Ultimate55% OFF

20 Microns Limited (20MICRONS) AI Stock Analysis

IN:20MICRONS

20 Microns Limited

(NSE:20MICRONS)

Select Model
Rating:69Neutral
Price Target:INR 176.00â–²(8.74% Upside)
Action:downgraded
Date:10/29/26

Solid financial performance with consistent growth and balance sheet improvement is the primary driver, tempered by weak technical momentum; attractive low P/E valuation provides meaningful support.

Positive Factors
Improving Balance SheetFalling leverage and rising equity improve financial flexibility and reduce balance-sheet strain. This gives 20 Microns greater capacity to fund operations, withstand demand fluctuations, and pursue measured growth without relying as heavily on debt.
Negative Factors
Slowing Revenue GrowthThe sharp deceleration in revenue growth signals weaker recent expansion in the company’s addressable demand or customer volumes. If low growth persists, operating leverage and the pace of earnings compounding could remain constrained over the next several quarters.

20 Microns Limited (20MICRONS) vs. iShares MSCI India ETF (INDA)

-40%-30%-20%-10%0%10%IN:20MICRONS-24.59%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 5.70B
Dividend Yield
0.77%
Average Volume (3M)
11.53K
Price to Earnings (P/E)
8.9
Beta (1Y)
1.11
Revenue Growth
4.21%
EPS Growth
2.66%
Country
India
Employees
413
Sector
General
Sector Strength
55
Industry
Industrial Materials

20 Microns Limited Business Overview & Revenue Model

Company Description

Founded in 1987 and based in Vadodara, India, 20 Microns Limited operates as a leading Indian producer and exporter of micronized industrial minerals and specialized chemical additives. The company offers an extensive portfolio of industrial minerals...

How the Company Makes Money

20 Microns makes money primarily by selling processed mineral products (micronized minerals, functional fillers, and other mineral-based specialty products) to industrial customers, typically on a B2B basis. Revenue is generated through: (1) Sale of...

20 Microns Limited Financial Statement Overview

Summary

Robust financial health with steady revenue and profit growth, strengthening balance sheet, and recovering cash flows, offset by margin volatility and cash flow inconsistencies.

Income Statement

78Positive

Balance Sheet

82Very Positive

Cash Flow

68Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.51B9.54B9.17B7.76B7.02B6.11B
Gross Profit3.41B3.41B4.31B2.77B3.24B2.20B
EBITDA1.27B1.28B1.21B994.95M868.22M815.54M
Net Income677.47M668.26M623.76M560.70M418.19M345.85M
Balance Sheet
Total Assets07.56B7.15B5.90B5.24B5.15B
Cash, Cash Equivalents and Short-Term Investments735.84M818.89M312.98M606.82M202.82M135.41M
Total Debt01.56B1.65B1.22B1.08B1.23B
Total Liabilities-4.87B2.69B2.80B2.36B2.29B2.63B
Stockholders Equity4.87B4.84B4.29B3.53B2.94B2.51B
Cash Flow
Free Cash Flow367.06M616.98M-448.94M345.62M507.09M79.27M
Operating Cash Flow524.39M880.57M317.86M544.43M631.97M353.20M
Investing Cash Flow-193.56M-325.39M-632.56M-204.69M-176.74M-231.72M
Financing Cash Flow-150.13M-132.33M140.21M-55.10M-379.73M-36.04M

20 Microns Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price161.85

Price Trends

50DMA203.45Negative
100DMA199.42Negative
200DMA186.29Negative

Market Momentum

MACD-10.56Positive
RSI31.78Neutral
STOCH16.27Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:20MICRONS, the sentiment is Negative. The current price of 161.85 is below the 20-day moving average (MA) of 188.69, below the 50-day MA of 203.45, and below the 200-day MA of 186.29, indicating a bearish trend. The MACD of -10.56 indicates Positive momentum. The RSI at 31.78 is Neutral, neither overbought nor oversold. The STOCH value of 16.27 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:20MICRONS.

20 Microns Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:20MICRONS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:MANALIPETCIN:MANALIPETC70OutperformINR 11.77B6.53―0.73%19.19%487.80%
IN:20MICRONSIN:20MICRONS69NeutralINR 5.71B8.90―0.77%4.21%2.66%
IN:ASHAPURMININ:ASHAPURMIN67NeutralINR 39.07B9.59―0.49%62.64%17.34%
IN:PLASTIBLENIN:PLASTIBLEN58NeutralINR 4.15B9.00―1.88%9.17%40.71%
IN:BODALCHEMIN:BODALCHEM57NeutralINR 20.74B30.19――27.57%135.05%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

0%100%200%IN:20MICRONSIN:ASHAPURMININ:BODALCHEMIN:SUDARCOLORIN:MANALIPETCIN:PLASTIBLENDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:20MICRONS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:20MICRONS20 Microns Limited161.85-54.52-25.20%
IN:ASHAPURMINAshapura Minechem Ltd409.00-263.37-39.17%
IN:BODALCHEMBodal Chemicals Limited164.70102.36164.20%
IN:SUDARCOLORHeubach Colorants India Limited370.95-146.90-28.37%
IN:MANALIPETCManali Petrochemicals Limited68.42-5.12-6.97%
IN:PLASTIBLENPlastiblends India Limited159.80-16.75-9.49%

20 Microns Limited Corporate Events

20 Microns Board Approves Q2 and Half-Year FY2026 Results

Oct 28, 2026

20 Microns Limited has announced that its Board of Directors met on October 28, 2026, to review the company’s performance for the latest reporting period. The meeting, held in compliance with SEBI listing requirements, underscores the company&#...

20 Microns Schedules Investor Call on Q2 FY2026 Results

Oct 26, 2026

20 Microns Limited has scheduled an investors’ earnings call on October 30, 2026, to discuss its unaudited standalone and consolidated financial results for the quarter ended September 30, 2026. The call, hosted on the VOSMOS Webinar platform,...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 29, 2026